Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 13 Recruiting 10 Completed 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Gemcitabine 13 Specimen Handling 12 Radiotherapy 12 Androgen Antagonists 12 Magnetic Resonance Spectroscopy 10 Nivolumab 9 pembrolizumab 8 darolutamide 7 Drug Therapy 7 toripalimab 6 Radiosurgery 6 Docetaxel 6 Cystectomy 6 enzalutamide 5 apalutamide 5 Mitomycin 5 Cisplatin 5 Abiraterone Acetate 5 disitamab vedotin 4 cabozantinib 4 abiraterone 4 Pluvicto 4 Ipilimumab 4 Cyclophosphamide 4 Biopsy 4 Axitinib 4 tislelizumab 3 lenvatinib 3 fludarabine 3 cemiplimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × belzutifan × Genitourinary × Clear all

NCT07593040 2026-05-20

Moonlanding

Vall d'Hebron Institute of Oncology

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡